- Home >
- Clinicals Trials >
- TOPOLOGY
Retour à la liste des essais cliniquesBreast cancer
TOPOLOGY
A phase II study to evaluate the efficacy and toxicities;of PLX038, in patients with locally advanced or metastatic triple-negative breast cancer.
- Ouvert à Paris depuis le : 29/02/2024
- Ouvert à Saint-Cloud depuis le : 14/02/2024
- Public cible : Adult
- Phase : Phase II
Description de l'essai
Efficacy of PLX038 on response rate.;Primary endpoint:;Best tumor response (defined as PR or CR in the first 6 months of treatment, assessed by investigators per RECIST v1.1 criteria).
Url of the trialInvestigateur principal
